[1] Pontes FS, Carneiro JT Jr, Fonseca FP, et al.Squamous cell carcinoma of the tongue and floor of the mouth: analysis of survival rate and independent prognostic factors in the Amazon region[J]. J Craniofac Surg, 2011, 22(3): 925-930.
[2] Zou B, Sun S, Qi X, et al.Aldehyde dehydrogenase activity is a cancer stem cell marker of tongue squamous cell carcinoma[J]. Mol Med Rep, 2012, 5(4):1116-1120.
[3] Cao L, Bombard J, Cintron K, et al.BMI1 as a novel target for drug discovery in cancer[J]. J Cell Biochem, 2011, 112(10): 2729-2741.
[4] Song LB, Li J, Liao WT, et al.The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells[J]. J Clin Invest, 2009, 119(12): 3626-3636.
[5] Paranjape AN, Balaji SA, Mandal T, et al.Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog[J]. BMC Cancer, 2014, 14: 785.
[6] Li DW, Tang HM, Fan JW, et al.Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer[J]. J Cancer Res Clin Oncol, 2010, 136(7): 997-1006.
[7] Du J, Li Y, Li J, et al.Polycomb group protein Bmi1 expression in colon cancers predicts the survival[J]. Med Oncol, 2010, 27(4):1273-1276.
[8] Kreso A, van Galen P, Pedley NM, et al. Self-renewal as a therapeutic target in human colorectal cancer[J]. Nat Med, 2014, 20(1): 29-36.
[9] Seo E, Basu-Roy U, Zavadil J, et al.Distinct functions of Sox2 control self-renewal and differentiation in the osteoblast lineage[J]. Mol Cell Biol, 2011, 31(22): 4593-4608.
[10] Feng JQ, Xu ZY, Shi LJ, et al.Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer[J]. J Oral Pathol Med, 2013, 42(2): 148-153.
[11] Tsai LL, Yu CC, Chang YC, et al.Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma[J]. J Oral Pathol Med, 2011, 40(8): 621-628.
[12] Li Z, Wang Y, Yuan C, et al.Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer[J]. Lab Invest, 2014, 94(12): 1431-1445.
[13] Gialmanidis IP, Bravou V, Petrou I, et al.Expression of Bmi1, FoxF1, Nanog, and gamma-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer[J]. Lung, 2013, 191(5): 511-521.
[14] Major AG, Pitty LP, Farah CS.Cancer stem cell markers in head and neck squamous cell carcinoma[J]. Stem Cells Int, 2013, 2013: 319489.
[15] Chou CH, Yang NK, Liu TY, et al.Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer[J]. Cancer Res, 2013, 73(2): 953-966.
[16] Prince ME, Sivanandan R, Kaczorowski A, et al.Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma[J]. Proc Natl Acad Sci USA, 2007, 104(3): 973-978. |